Cdk5: One of the links between senile plaques and neurofibrillary tangles?

Journal of Alzheimer's Disease

Volumn 5, Issue 2, 2003, Pages 127-137

  Lee, Ming Sum ^a   Tsai, Li Huei ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALPAIN; CYCLIN DEPENDENT KINASE 5; PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN P25; PROTEIN P35; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 0038705066     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2003-5207     Document Type: Review

References (93)

1. D.J. Selkoe, Translating cell biology into therapeutic advances in Alzheimer's disease, Nature 6738 (1999), A23-31.
2. V.M. Lee, M. Goedert and J.Q. Trojanowski, Neurodegenerative tauopathies, Annu Rev Neurosci (2001), 1121-1159.
3. D.L. Price, R.E. Tanzi, D.R. Borchelt and S.S. Sisodia, Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet (1998), 461-493.
4. I.R. Mackenzie, R.S. McLachlan, C.S. Kubu and L.A. Miller, Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques, Neurology 2 (1996), 425-429.
5. V.P. Prasher, M.J. Farrer, A.M. Kessling, E.M. Fisher, R.J. West, P.C. Barber and A.C. Butler, Molecular mapping of Alzheimer-type dementia in Down's syndrome, Ann Neurol 3 (1998), 380-383.
6. J. Busciglio, A. Lorenzo, J. Yeh and B.A. Yankner, beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding, Neuron 4 (1995), 879-888.
7. C. Geula, C.K. Wu, D. Saroff, A. Lorenzo, M. Yuan and B.A. Yankner, Aging renders the brain vulnerable to amyloid betaprotein neurotoxicity, Nat Med 7 (1998), 827-831.
8. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang and G. Cole, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science 5284 (1996), 99-102.
9. D. Moechars, I. Dewachter, K. Lorent, D. Reverse, V. Baekelandt, A. Naidu, I. Tesseur, K. Spittaels, C.V. Haute, F. Checler, E. Godaux, B. Cordell and F. Van Leuven, Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 10 (1999), 6483-6492.
10. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson and F. Gillespie et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, Nature 6514 (1995), 523-527.
11. J. Gotz, F. Chen, J. van Dorpe and R.M. Nitsch, Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils, Science 5534 (2001), 1491-1495.
12. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton and E. McGowan, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science 5534 (2001), 1487-1491.
13. G. Chen, K.S. Chen, J. Knox, J. Inglis, A. Bernard, S.J. Martin, A. Justice, L. McConlogue, D. Games, S.B. Freedman and R.G. Morris, A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease, Nature 6815 (2000), 975-979.
14. C. Janus, J. Pearson, J. McLaurin, P.M. Mathews, Y. Jiang, S.D. Schmidt, M.A. Chishti, P. Horne, D. Heslin, J. French, H.T. Mount, R.A. Nixon, M. Mercken, C. Bergeron, P.E. Fraser, P. St George-Hyslop and D. Westaway, A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease, Nature 6815 (2000), 979-982.
15. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, J. Hardy, K. Duff, P. Jantzen, G. DiCarlo, D. Wilcock, K. Connor, J. Hatcher, C. Hope, M. Gordon and G.W. Arendash, A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease, Nature 6815 (2000), 982-985.
16. K. Imahori and T. Uchida, Physiology and pathology of tau protein kinases in relation to Alzheimer's disease, J Biochem (Tokyo) 2 (1997), 179-188.
17. K. Sobue, A. Agarwal-Mawal, W. Li, W. Sun, Y. Miura and H.K. Paudel, Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau, J Biol Chem 22 (2000), 16673-16680.
18. K. Ishiguro, K. Sato, M. Takamatsu, J. Park, T. Uchida and K. Imahori, Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites, Neurosci Lett 1-2 (1995), 81-84.
19. K. Baumann, E.M. Mandelkow, J. Biernat, H. Piwnica-Worms and E. Mandelkow, Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin- dependent kinases cdk2 and cdk5, FEBS Lett 3 (1993), 417-424.
20. E.T. Lund, R. McKenna, D.B. Evans, S.K. Sharma and W.R. Mathews, Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry, J Neurochem 4 (2001), 1221-1232.
21. D.B. Flaherty, J.P. Soria, H.G. Tomasiewicz and J.G. Wood, Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants, J Neurosci Res 3 (2000), 463-472.
22. W.K. Liu, R.T. Williams, F.L. Hall, D.W. Dickson and S.H. Yen, Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments, Am J Pathol 1 (1995), 228-238.
23. H. Yamaguchi, K. Ishiguro, T. Uchida, A. Takashima, C.A. Lemere and K. Imahori, Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclindependent kinase 5, a component of TPK II, Acta Neuropathol (Berl) 3 (1996), 232-241.
24. J.J. Pei, I. Grundke-Iqbal, K. Iqbal, N. Bogdanovic, B. Winblad and R.F. Cowburn, Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration, Brain Res 2 (1998), 267-277.
25. J.C. Augustinack, J.L. Sanders, L.H. Tsai and B.T. Hyman, Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in preneurofibrillary tangles and neurofibrillary tangles, Journal of Neuropathology & Experimental Neurology 6 (2002), 557-564.
26. K.Y. Lee, A.W. Clark, J.L. Rosales, K. Chapman, T. Fung and R.N. Johnston, Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain, Neurosci Res 1 (1999), 21-29.
27. A. Alvarez, J.P. Munoz and R.B. Maccioni, A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons, Exp Cell Res 2 (2001), 266-274.
28. Y. Tomidokoro, K. Ishiguro, Y. Harigaya, E. Matsubara, M. Ikeda, J.M. Park, K. Yasutake, T. Kawarabayashi, K. Okamoto and M. Shoji, Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice, Neurosci Lett 3 (2001), 169-172.
29. M. Meyerson, G.H. Enders, C.L. Wu, L.K. Su, C. Gorka, C. Nelson, E. Harlow and L.H. Tsai, A family of human cdc2-related protein kinases, Embo J 8 (1992), 2909-2917.
30. K. Ishiguro, M. Takamatsu, K. Tomizawa, A. Omori, M. Takahashi, M. Arioka, T. Uchida and K. Imahori, Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments, J Biol Chem 15 (1992), 10897-10901.
31. J. Lew, R.J. Winkfein, H.K. Paudel and J.H. Wang, Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2, J Biol Chem 36 (1992), 25922-25926.
32. K. Ishiguro, S. Kobayashi, A. Omori, M. Takamatsu, S. Yonekura, K. Anzai, K. Imahori and T. Uchida, Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain, FEBS Lett 2 (1994), 203-208.
33. J. Lew, Q.Q. Huang, Z. Qi, R.J. Winkfein, R. Aebersold, T. Hunt and J.H. Wang, A brain-specific activator of cyclin-dependent kinase 5. Nature 6496 (1994), 423-426.
34. L.H. Tsai, I. Delalle, V.S. Caviness, Jr., T. Chae and E. Harlow, p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5, Nature 6496 (1994), 419-423.
35. D. Tang, J. Yeung, K.Y. Lee, M. Matsushita, H. Matsui, K. Tomizawa, O. Hatase and J.H. Wang, An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator, J Biol Chem 45 (1995), 26897-26903.
36. D. Tang, A.C. Chun, M. Zhang and J.H. Wang, Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator. Evidence of the existence of cyclin fold in neuronal Cdk5a activator, J Biol Chem 19 (1997), 12318-12327.
37. C. Tarricone, R. Dhavan, J. Peng, L.B. Areces, L.H. Tsai and A. Musacchio, Structure and regulation of the CDK5-p25(nck5a) complex, Mol Cell 3 (2001), 657-669.
38. L.H. Tsai, T. Takahashi, V.S. Caviness, Jr. and E. Harlow, Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system, Development 4 (1993), 1029-1040.
39. M. Zheng, C.L. Leung and R.K. Liem, Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system, J Neurobiol 2 (1998), 141-159.
40. T. Ohshima, J.M. Ward, C.G. Huh, G. Longenecker, Veeranna, H.C. Pant, R.O. Brady, L.J. Martin and A.B. Kulkarni, Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death, Proc Natl Acad Sci USA 20 (1996), 11173-11178.
41. J. Ko, S. Humbert, R.T. Bronson, S. Takahashi, A.B. Kulkarni, E. Li and L.H. Tsai, p35 and p39 are essential for cyclin- dependent kinase 5 function during neurodevelopment, J Neurosci 17 (2001), 6758-6771.
42. T. Chae, Y.T. Kwon, R. Bronson, P. Dikkes, E. Li and L.H. Tsai, Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality, Neuron 1 (1997), 29-42.
43. T. Ohshima, E.C. Gilmore, G. Longenecker, D.M. Jacobowitz, R.O. Brady, K. Herrup and A.B. Kulkarni, Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous, J Neurosci 14 (1999), 6017-6026.
44. L. Connell-Crowley, M. Le Gall, D.J. Vo and E. Giniger, The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo, Curr Biol 10 (2000), 599-602.
45. M. Nikolic, H. Dudek, Y.T. Kwon, Y.F. Ramos and L.H. Tsai, The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation, Genes Dev 7 (1996), 816-825.
46. G. Pigino, G. Paglini, L. Ulloa, J. Avila and A. Caceres, Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons, J Cell Sci Pt 2 (1997), 257-270.
47. F. Ledda, G. Paratcha and C.F. Ibanex, Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5, Neuron 3 (2002), 387-401.
48. Y. Sasaki, C. Cheng, Y. Uchida, O. Nakajima, T. Ohshima, T. Yagi, M. Taniguchi, T. Nakayama, R. Kishida, Y. Kudo, S. Ohno, F. Nakamura and Y. Goshima, Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex, Neuron 5 (2002), 907-920.
49. M. Nikolic, M.M. Chou, W. Lu, B.J. Mayer and L.H. Tsai, The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity, Nature 6698 (1998), 194-198.
50. T. Rashid, M. Banerjee and M. Nikolic, Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology, J Biol Chem 52 (2001), 49043-49052.
51. A. Sengupta, J. Kabat, M. Novak, Q. Wu, I. Grundke-Iqbal and K. Iqbal, Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules, Arch Biochem Biophys 2 (1998), 299-309.
52. B. Trinczek, J. Biernat, K. Baumann, E.M. Mandelkow and E. Mandelkow, Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules, Mol Biol Cell 12 (1995), 1887-1902.
53. Y. Wada, K. Ishiguro, T.J. Itoh, T. Uchida, H. Hotani, T. Saito, T. Kishimoto and S. Hisanaga, Microtubule-stimulated phosphorylation of tau at Ser202 and Thr205 by cdk5 decreases its microtubule nucleation activity, J Biochem (Tokyo) 4 (1998), 738-746.
54. P. Grant, P. Sharma and H.C. Pant, Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism, Eur J Biochem 6 (2001), 1534-1546.
55. Y.T. Kwon, A. Gupta, Y. Zhou, M. Nikolic and L.H. Tsai, Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase, Curr Biol 7 (2000), 363-372.
56. S. Kesavapany, K.F. Lau, D.M. McLoughlin, J. Brownlees, S. Ackerley, P.N. Leigh, C.E. Shaw and C.C. Miller, p35/cdk5 binds and phosphorylates beta-catenin and regulates betacatenin/presenilin-1 interaction, Eur J Neurosci 2 (2001), 241-247.
57. M. Niethammer, D.S. Smith, R. Ayala, J. Peng, J. Ko, M.S. Lee, M. Morabito and L.H. Tsai, NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein, Neuron 3 (2000), 697-711.
58. A. Fischer, F. Sananbenesi, C. Schrick, J. Spiess and J. Radulovic, Cyclin-dependent kinase 5 is required for associative learning, Journal of Neuroscience 9 (2002), 3700-3707.
59. R. Dhavan, P.L. Greer, M.A. Morabito, L.R. Orlando and L.H. Tsai, The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner, Journal of Neuroscience 18 (2002), 7879-7891.
60. A.I. Fletcher, R. Shuang, D.R. Giovannucci, L. Zhang, M.A. Bittner and E.L. Stuenkel, Regulation of exocytosis by cyclindependent kinase 5 via phosphorylation of Munc18, J Biol Chem 7 (1999), 4027-4035.
61. S.R. Floyd, E.B. Porro, V.I. Slepnev, G.C. Ochoa, L.H. Tsai and P. De Camilli, Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2, J Biol Chem 11 (2001), 8104-8110.
62. R. Shuang, L. Zhang, A. Fletcher, G.E. Groblewski, J. Pevsner and E.L. Stuenkel, Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings, J Biol Chem 9 (1998), 4957-4966.
63. K. Tomizawa, J. Ohta, M. Matsushita, A. Moriwaki, S.T. Li, K. Takei and H. Matsui, Cdk5/p35 Regulates Neurotransmitter Release through Phosphorylation and Downregulation of P/Q-Type Voltage-Dependent Calcium Channel Activity, J Neurosci 7 (2002), 2590-2597.
64. B.S. Li, M.K. Sun, L. Zhang, S. Takahashi, W. Ma, L. Vinade, A.B. Kulkarni, R.O. Brady and H.C. Pant, Regulation of NMDA receptors by cyclin-dependent kinase-5, Proc Natl Acad Sci USA 22 (2001), 12742-12747.
65. J.A. Bibb, G.L. Snyder, A. Nishi, Z. Yan, L. Meijer, A.A. Fienberg, L.H. Tsai, Y.T. Kwon, J.A. Girault, A.J. Czernik, R.L. Huganir, H.C. Hemmings, Jr., A.C. Nairn and P. Greengard, Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons, Nature 6762 (1999), 669-671.
66. J.A. Bibb, J. Chen, J.R. Taylor, P. Svenningsson, A. Nishi, G.L. Snyder, Z. Yan, Z.K. Sagawa, C.C. Ouimet, A.C. Nairn, E.J. Nestler and P. Greengard, Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5, Nature 6826 (2001), 376-380.
67. J.L. Rosales, M.J. Nodwell, R.N. Johnston and K.Y. Lee, Cdk5/p25(nck5a) interaction with synaptic proteins in bovine brain, J Cell Biochem 1 (2000), 151-159.
68. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes and L.H. Tsai, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration, Nature 6762 (1999), 615-622.
69. S. Humbert, R. Dhavan and L. Tsai, p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton, J Cell Sci Pt 6 (2000), 975-983.
70. G.N. Patrick, P. Zhou, Y.T. Kwon, P.M. Howley and L.H. Tsai, p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway, J Biol Chem 37 (1998), 24057-24064.
71. L.R. Zukerberg, G.N. Patrick, M. Nikolic, S. Humbert, C.L. Wu, L.M. Lanier, F.B. Gertler, M. Vidal, R.A. Van Etten and L.H. Tsai, Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth, Neuron 3 (2000), 633-646.
72. I. Matsuura and J.H. Wang, Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus, J Biol Chem 10 (1996), 5443-5450.
73. P. Sharma, M. Sharma, N.D. Amin, R.W. Albers and H.C. Pant, Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation, Proc Natl Acad Sci USA 20 (1999), 11156-11160.
74. F. Liu, X.H. Ma, J. Ule, J.A. Bibb, A. Nishi, A.J. DeMaggio, Z. Yan, A.C. Nairn and P. Greengard, Regulation of cyclin- dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors, Proc Natl Acad Sci USA 20 (2001), 11062-11068.
75. M.H. Lee, M. Nikolic, C.A. Baptista, E. Lai, L.H. Tsai and J. Massague, The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons, Proc Natl Acad Sci USA 8 (1996), 3259-3263.
76. Y.P. Ching, A.S. Pang, W.H. Lam, R.Z. Qi and J.H. Wang, Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor, J Biol Chem (2002), 6.
77. K.Y. Lee, J.L. Rosales, D. Tang and J.H. Wang, Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain, J Biol Chem 3 (1996), 1538-1543.
78. M. Moorthamer and B. Chaudhuri, Identification of ribosomal protein L34 as a novel Cdk5 inhibitor, Biochem Biophys Res Commun 3 (1999), 631-638.
79. M. Moorthamer, S. Zumstein-Mecker and B. Chaudhuri, DNA binding protein dbpA binds Cdk5 and inhibits its activity, FEBS Lett 2-3 (1999), 343-350.
80. J. Chen, Y. Zhang, M.B. Kelz, C. Steffen, E.S. Ang, L. Zeng and E.J. Nestler, Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of [Delta]FosB, J Neurosci 24 (2000), 8965-8971.
81. T. Harada, T. Morooka, S. Ogawa and E. Nishida, ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1, Nat Cell Biol 5 (2001), 453-459.
82. R.J. McEvilly, M.O. de Diaz, M.D. Schonemann, F. Hooshmand and M.G. Rosenfeld, Transcriptional regulation of cortical neuron migration by POU domain factors, Science 5559 (2002), 1528-1532.
83. S. Taniguchi, Y. Fujita, S. Hayashi, A. Kakita, H. Takahashi, S. Murayama, T.C. Saido, S. Hisanaga, T. Iwatsubo and M. Hasegawa, Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains, FEBS Letters 1 (2001), 46-50.
84. B.C. Yoo and G. Lubec, p25 protein in neurodegeneration, Nature 6839 (2001), 763-764; discussion 764-765.
85. H.C. Tseng, Y. Zhou, Y. Shen and L.H. Tsai, A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains, FEBS Letters 1-3 (2002), 58-62.
86. M.K. Ahlijanian, N.X. Barrezueta, R.D. Williams, A. Jakowski, K.P. Kowsz, S. McCarthy, T. Coskran, A. Carlo, P.A. Seymour, J.E. Burkhardt, R.B. Nelson and J.D. McNeish, Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5, Proc Natl Acad Sci USA 6 (2000), 2910-2915.
87. C. Van den Haute, K. Spittaels, J. Van Dorpe, R. Lasrado, K. Vandezande, I. Laenen, H. Geerts and F. Van Leuven, Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice, Neurobiol Dis 1 (2001), 32-44.
88. M. Hashiguchi, T. Saito, S. Hisanaga and T. Hashiguchi, Truncation of CDK5 activator p35 induces intensive phosphorylation on Ser202/Thr205 of human tau, J Biol Chem 46 (2002), 44525-44530.
89. M.S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander and L.H. Tsai, Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature 6784 (2000), 360-364.
90. R. Nath, M. Davis, A.W. Probert, N.C. Kupina, X. Ren, G.P. Schielke and K.K. Wang, Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells, Biochem Biophys Res Commun 1 (2000), 16-21.
91. P. Kerokoski, T. Suuronen, A. Salminen, H. Soininen and T. Pirttila, Influences of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5) on the proteolysis of p35, Brain Res Mol Brain Res 1-2 (2002), 50.
92. K.K.K. Wang and P.-W. Yuen, Calpain: pharmacology and toxicology of calcium-dependent protease, Taylor&Francis, Philadelphia, PA, 1999.
93. A. Alvarez, R. Toro, A. Caceres and R.B. Maccioni, Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death, FEBS Lett 3 (1999), 421-426.